Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Controlled Clinical Study Of NuShield® and Standard of Care (SOC) Compared to SOC Alone For The Management Of Diabetic Foot Ulcers

NCT03855514 is registered in ClinicalTrials.gov with Organogenesis as lead sponsor.

NCT NCT03855514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03855514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Controlled Clinical Study Of NuShield® and Standard of Care (SOC) Compared to SOC Alone For The Management Of Diabetic Foot Ulcers
Lead sponsor
Organogenesis
Phase
Not applicable
Overall status
Unknown status
Start date
February 8, 2019
Completion date
December 30, 2021
Enrollment
200 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer